News

Media focus

Industry News

News

High-quality research helps consistency evaluation, and the cooperative enterprise MAH will catch up with the new round of collection after being newly approved

High-quality research helps consistency evaluation, and the cooperative enterprise MAH will catch up with the new round of collection after being newly approved

The dust of the seven batches of centralized procurement has not yet been settled. Centralized procurement at the national and local levels has become normalized, triggering the reshaping of the industry and earth-shaking changes in rules. If a company is not fully prepared, does not change, accept and learn, and fails to improve, update, expand product pipelines, and reserve superior products, it will be a matter of time before it falls behind.

19

2022

/

07

Phase II clinical trial of Novavax respiratory syncytial virus vaccine shows promising results

Phase II clinical trial of Novavax respiratory syncytial virus vaccine shows promising results

Recently, NOVAVAX announced that its first respiratory syncytial virus vaccine, RSV F (RSV F protein recombinant nanoparticle vaccine), which it led the development of, has obtained good results in a phase II trial of elderly patients aged 60 and above with respiratory syncytial virus (RSV). Outstanding performance. The results showed that the RSV F vaccine was well tolerated and achieved both the primary and secondary clinical endpoints.

24

2018

/

05

Diabetes Care: Metformin lowers cholesterol levels in people with diabetes

Diabetes Care: Metformin lowers cholesterol levels in people with diabetes

In addition to affecting blood sugar levels, metformin also affects blood lipid levels. In a recent research paper published in the international magazine Diabetes Care, researchers from the German Diabetes Research Center found that metformin may also affect the body's blood lipid levels. In particular, levels of harmful LDL cholesterol can be reduced.

24

2018

/

05

Merck's $17 billion acquisition of Sigma-Aldrich receives full antitrust approval

Merck's $17 billion acquisition of Sigma-Aldrich receives full antitrust approval

Merck KGaA recently announced that its US$17 billion cash acquisition of Sigma-Aldrich (hereinafter referred to as Sigma), the world's largest chemical reagent manufacturer, has been approved by the antitrust departments of all relevant jurisdictions. approve. The acquisition is expected to be completed in the third quarter of 2015.

24

2018

/

05

Plos pathogens: New hope for influenza prevention and treatment: You can prevent influenza without vaccination

Plos pathogens: New hope for influenza prevention and treatment: You can prevent influenza without vaccination

Recently, researchers from The Ohio State University in the United States have discovered a new method that can trigger the body's protective response to influenza virus infection without the action of viruses or interferons. Relevant research results were published in the international academic journal plos pathogens.

24

2018

/

05

AbbVie’s anticancer drug venetoclax succeeds in pivotal Phase II clinical trial for refractory blood cancer

AbbVie’s anticancer drug venetoclax succeeds in pivotal Phase II clinical trial for refractory blood cancer

Recently, venetoclax, an oncology drug jointly developed by Roche and AbbVie, was successful in a pivotal Phase II clinical trial (M13-982) for blood cancers, paving the way for the drug's regulatory application. . AbbVie plans to submit marketing applications for venetoclax to the United States (FDA) and the European Union (EMA) by the end of the year. Some analysts cannot help but predict that venetoclax is likely to become a blockbuster drug.

24

2018

/

05

< 1 >